Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

Historic Stock Lookup

Historic Stock Lookup

Week of April 22, 2024

Date Requested Closing Price Volume Split Adjustment Factor Open Price Day High Day Low
April 22, 2024 $90.61 792,073 1:1 $87.76 $92.66 $86.52
April 23, 2024 $92.29 788,709 1:1 $90.48 $94.67 $89.19
April 24, 2024 $92.26 588,540 1:1 $91.78 $93.74 $90.43
April 25, 2024 $90.73 755,177 1:1 $89.54 $91.46 $88.46

NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown. The closing price is not necessarily indicative of future price performance.

Data Provided by Refinitiv. Minimum 15 minutes delayed.